Related Experiment Video
Updated: Jun 5, 2026
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Targeted removal of migratory tumor cells by functionalized magnetic nanoparticles impedes metastasis and tumor
Kenneth E Scarberry1, Roman Mezencev, John F McDonald
1School of Biology & Petit Institute of Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA 30332, USA.
Aims:
To slow tumor progression by reducing migratory tumor cell burden using magnetic nanoparticles (MNPs) functionalized with ligands selective for malignant cell surface receptors.
Materials & Methods:
Three groups of female C57BL/6 mice (control group I, control group II and experimental group) were intraperitoneally injected with a murine ovarian cancer cell line (ID8[VEGF160(+)/eGFP(+)]). Control group I received no intervention. MNPs were functionalized with ephrin-A1 mimetic peptides selective for the EphA2 receptor that is highly expressed by several cancers. Peritoneal fluids were removed by paracentesis from the experimental group and mixed with the functionalized MNPs. Magnetic filtration was used to remove particle/malignant cell conjugates and filtered peritoneal fluids were re-introduced intraperitoneally. Control group II received the same treatment as the experimental group without MNPs.
Results:
Experimental group tumor progression was 10.77-times slower than that of control group I.
Conclusion:
Reduction of malignant cell titer significantly prolonged time to end point in a metastatic ovarian cancer model.
Insights
Magnetic nanoparticles (MNPs) functionalized with selective ligands were used to reduce malignant cell burden in an ovarian cancer model. This approach significantly slowed tumor progression, offering a novel therapeutic strategy.
Area of Science:
- Oncology
- Biotechnology
- Nanomedicine
Background:
- Ovarian cancer is a leading cause of cancer-related death.
- Tumor cell migration and burden are key factors in metastatic disease progression.
- Targeted therapies are needed to reduce tumor burden and improve patient outcomes.
Purpose of the Study:
- To develop and evaluate magnetic nanoparticles (MNPs) for reducing migratory tumor cell burden.
- To functionalize MNPs with ligands targeting specific malignant cell surface receptors, such as EphA2.
- To assess the efficacy of MNP-mediated tumor cell reduction in slowing ovarian cancer progression.
Main Methods:
- Murine ovarian cancer cells (ID8) were used in a C57BL/6 mouse model.
- MNPs were functionalized with ephrin-A1 mimetic peptides targeting the EphA2 receptor.
- Malignant cells were captured using MNPs and magnetic filtration from peritoneal fluid, followed by re-infusion.
Main Results:
- The experimental group treated with functionalized MNPs showed a 10.77-fold slower tumor progression compared to the untreated control group.
- Reduction of malignant cell titer was demonstrated as an effective method to slow disease progression.
- The MNP-based approach successfully reduced the burden of migratory tumor cells.
Conclusions:
- Targeted reduction of malignant cell titer using functionalized MNPs significantly prolongs survival in a metastatic ovarian cancer model.
- This MNP-based strategy represents a promising approach for managing ovarian cancer progression.
- Further research into MNP-targeted therapies could lead to improved clinical outcomes for ovarian cancer patients.
Related Concept Videos
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...